The Cooper Companies Inc. (COO) is scheduled to release Q315 earnings after the close today. The Street is looking for EPS of $1.95 and revenue of $464.12 million. Last quarter, the company posted a significant negative earnings surprise of 2.27%, reporting EPS of $1.72, $0.04 lower than the Street’s consensus estimate of $1.76. Revs however, increased 5.43% year-over-year to $434.7 million versus the $412.3 million reported. Meanwhile, EarningsWhisper.com reports a whisper number of $2.01 per share.
Shares of Cooper Companies are currently printing a higher than average trading volume with the issue trading 256K shares, compared to the average volume of 397.56K. The stock began trading this morning at $163.24 to currently trade 55c higher from the prior days close of $162.40. On an intraday basis it got as low as $162.74 and as high as $164.48.
On valuation measures, COO shares are currently priced at 33.28x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 7.75x earnings multiple. The company’s current year and next year EPS growth estimates stand at 3.70% and 15.20%, compared to the industry growth rates of (11.50%) and 49.10%, respectively. Cooper Co.’s has a t-12 price/sales ratio of 4.43. EPS for the same period registers at $4.90.
COO shares have declined 7.71% in the last 4 weeks and 9.83% in the past three months. Over the past 5 trading sessions the stock has gained 0.70%. The Pleasanton, California-based medical device company, which is currently valued at $7.92 billion, has a median Wall Street price target of $200.00 with a high target of $212.50.
COO is up 0.72% year-over-year and 0.23% year-to-date.